Aligos Therapeutics, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US01626L1052
USD
6.49
-1.03 (-13.7%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAligos Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
-13.7%
-0.51%
1W
-19.48%
-1.37%
1M
-28.92%
0.35%
YTD
-30.36%
0.54%
1Y
-75.07%
13.99%
3Y
270.86%
66.39%
5Y
-98.91%
77.77%
10Y
-98.91%
259.33%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-9.99%
0%
-9.99%
6 Months
-18.87%
0%
-18.87%
1 Year
-75.07%
0%
-75.07%
2 Years
-63.94%
0%
-63.94%
3 Years
270.86%
0%
270.86%
4 Years
-91.52%
0%
-91.52%
5 Years
-98.91%
0%
-98.91%

Aligos Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary